Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus

AIM: To describe our experience using a low-accelerating-dose regimen (LADR) with pegylated interferon alpha-2a and ribavirin in treatment of hepatitis C virus (HCV) recurrence. METHODS: From 2003, a protocolized LADR strategy was employed to treat liver transplant (LT) recipients with recurrent HCV...

詳細記述

保存先:
書誌詳細
出版年:World J Gastroenterol
主要な著者: Lim, Kieron BL, Sima, Hamid R, Fiel, M Isabel, Khaitova, Viktoriya, Doucette, John T, Chernyiak, Maria, Ahmad, Jawad, Bach, Nancy, Chang, Charissa, Grewal, Priya, Kim-Schluger, Leona, Liu, Lawrence, Odin, Joseph, Perumalswami, Ponni, Florman, Sander S, Schiano, Thomas D
フォーマット: Artigo
言語:Inglês
出版事項: Baishideng Publishing Group Inc 2015
主題:
Retrospective Study
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4445100/
https://ncbi.nlm.nih.gov/pubmed/26034358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i20.6236
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料